EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study

Cibelle Freitas Lima, Auriole Tamegnon, Saxon Rodriguez, Dipen Maru, Philip L Martin, Zachary A Cooper, Jaime Rodriguez-Canales, Edwin Roger Parra

Pathobiology · 2024

DOI: 10.1159/000534677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathobiology, 2024. Verfasst von Cibelle Freitas Lima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, cibellef09@gmail.com. Hauptthemen laut MEDLINE: Antigens, CD, Colorectal Neoplasms, Pancreatic Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Generating high levels of immunosuppressive adenosine (ADO) in the tumor microenvironment contributes to cancer immune evasion. CD39 and CD73 hydrolyze adenosine triphosphate into ADO; thus, efforts have been made to target this pathway for cancer immunotherapy. Our objective was optimizing a multiplex immunofluorescence (mIF) panel to explore the role of CD39 and CD73 within the tumor microenvironment. Materials and Methods: In three-time points, a small cohort (n = 8) of colorectal and pancreatic adenocarcinomas were automated staining using an mIF panel against CK, CD3, CD8, CD20, CD39, CD73, and CD68 to compare them with individual markers immunohistochemistry (IHC) for internal panel validation. Densities of immune cells and distances from different tumor-associated immune cells to tumor cells were exploratory assessment and compared with clinicopathologic variables and outcomes.

Results

Comparing the three-time points and individual IHC staining results, we demonstrated high reproducibility of the mIF panel. CD39 and CD73 expression was low in malignant cells; the exploratory analysis showed higher densities of CD39 expression by various cells, predominantly stromal cells, followed by T cells, macrophages, and B cells. No expression of CD73 by B cells or macrophages was detected. Distance analysis revealed proximity of cytotoxic T cells, macrophages, and T cells expressing CD39 to malignant cells, suggesting a close regulatory signal driven by this ADO marker.

Conclusions

We optimized an mIF panel for detection of markers in the ADO pathway, an emerging clinically relevant pathway. The densities and spatial distribution demonstrated that this pathway may modulate aspects of the tumor immune microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, CDColorectal NeoplasmsPancreatic NeoplasmsBiomarkers, TumorHumansPilot ProjectsFluorescent Antibody Technique, DirectAdenosine5'-NucleotidaseGPI-Linked ProteinsApyrase

Stichwörter der Autor:innen

Adenosine pathwayCD39CD73Colorectal adenocarcinomaMultiplex immunofluorescencePancreatic ductal adenocarcinoma

Substanzen

AdenosineAntigens, CDBiomarkers, TumorNT5E protein, human5'-NucleotidaseGPI-Linked ProteinsENTPD1 protein, humanApyraseCD39 antigen

Autor:innen und Institutionen

  • Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, cibellef09@gmail.com.
  • Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Departments of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA.

Zitieren

APA

Lima, C. F., Tamegnon, A., Rodriguez, S., Maru, D., Martin, P. L., Cooper, Z. A., Rodriguez-Canales, J., & Parra, E. R. (2024). Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study. Pathobiology. https://doi.org/10.1159/000534677

Vancouver

Lima CF, Tamegnon A, Rodriguez S, Maru D, Martin PL, Cooper ZA, et al. Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study. Pathobiology. 2024. doi:10.1159/000534677

BibTeX
@article{Lima2024,
  author = {Lima, Cibelle Freitas and Tamegnon, Auriole and Rodriguez, Saxon and Maru, Dipen and Martin, Philip L and Cooper, Zachary A and Rodriguez-Canales, Jaime and Parra, Edwin Roger},
  title = {Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study},
  journal = {Pathobiology},
  year = {2024},
  doi = {10.1159/000534677}
}
Kostenlos starten →